Expand HRTX Menu
HRTX MENU

Heron Therapeutics (HRTX) closed at $0.31 on November 13, 2026, down 4.8% from the previous close, on volume of 2,371,275 shares (30-day average 7,048,347).

Key numbers
  • Last close: $0.31 (November 13, 2026)
  • 52-week range: $0.26 to $1.58
  • Market value: $59.1 million
  • 30-day implied volatility (IV30): 90.1%
  • Option volume: 1 contracts (0 calls, 1 puts); 30-day average 1,647

Data as of November 13, 2026.

HRTX Stock Summary and Trading Ideas (Heron Therapeutics | NASDAQ:HRTX)

Charts for Today's Stock Price and Implied Volatility in Heron Therapeutics

13-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for HRTX by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days

Trading Statistics

Key Ratios

Heron Therapeutics (HRTX) Frequently Asked Questions

What does Heron Therapeutics do?

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

What symbol and exchange does Heron Therapeutics shares trade?

Heron Therapeutics trades on the NASDAQ stock market under the symbol HRTX.

What is Heron Therapeutics stock price doing today?

As of November 13, 2026, HRTX stock price declined to $0.31 with 2,371,275 million shares trading.

What is Heron Therapeutics's Beta?

HRTX has a beta of 3.12, meaning it tends to be more sensitive to market movements. HRTX has a correlation of 0.14 to the broad based SPY ETF.

How much is Heron Therapeutics worth?

HRTX has a market cap of $59.08 million. This is considered a Micro Cap stock.

How much money does Heron Therapeutics make?

Last quarter Heron Therapeutics reported $35 million in Revenue and -$.03 earnings per share. This fell short of revenue expectation by $-2 million and met earnings estimates .

What is the highest and lowest price Heron Therapeutics traded in the last 3 year period?

In the last 3 years, HRTX traded as high as $3.93 and as low as $.26.

What are the top ETFs holding Heron Therapeutics?

The top ETF exchange traded funds that HRTX belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

Is Heron Therapeutics (HRTX) a good investment?

HRTX has underperformed the market in the last year with a return of -72.0%, while the SPY ETF gained +13.4%. In the last 3 month period, HRTX fell short of the market, returning -7.1%, while SPY returned -2.8%. However, in the most recent 2 weeks HRTX has outperformed the stock market by returning +11.8%, while SPY returned -0.2%.

What are the support and resistance levels for Heron Therapeutics (HRTX)?

HRTX support price is $.30 and resistance is $.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HRTX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes